Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Valgus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    18 result(s) found for: Valgus. Displaying page 1 of 1.
    EudraCT Number: 2012-005705-49 Sponsor Protocol Number: POP3study Start Date*: 2013-01-24
    Sponsor Name:zna middelheim
    Full Title: “Comparison of the onset and duration of postoperative analgesia using a popliteal block with different concentrations of local anesthetics »
    Medical condition: In our first study we were able to prove that dexamethasone prolongs total block (sensory and motor block) duration as well as time to pain when dexamaethasone is used as an additive to naropin in ...
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004865 10011123 Correction Hallux Valgus LLT
    15.1 100000004865 10019095 Hallux Valgus correction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004863-30 Sponsor Protocol Number: MG Start Date*: 2014-01-14
    Sponsor Name:Università Campus Bio-Medico di Roma
    Full Title: EVALUATION OF EFFECT OF MAGNESIUM SULFATE ADDED TO THE ropivacaine for the sciatic nerve block at popliteus
    Medical condition: Hallux valgus correction
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004865 10011123 Correction Hallux Valgus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-005106-64 Sponsor Protocol Number: CWI-HVS Start Date*: 2014-03-20
    Sponsor Name:Medizinische Universität Innsbruck
    Full Title: Continous wound infiltration after hallux valgus surgery
    Medical condition: Hallux valgus surgery
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004865 10019095 Hallux Valgus correction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2007-005180-10 Sponsor Protocol Number: 9445-07 Start Date*: 2009-01-07
    Sponsor Name:Frederiksberg Hospital
    Full Title: Hvilken infusionshastighed for smertepumpen giver bedst smertelindring efter fodoperation?
    Medical condition: Patienter som skal forfods-opereres i dagkirurgisk regi
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019093 Hallux valgus LLT
    9.1 10019092 Hallux rigidus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006000-30 Sponsor Protocol Number: ForefootFenta vs.1 Start Date*: 2009-01-09
    Sponsor Name:Riika Merivirta
    Full Title: ”Postoperative pain treatment with fentanyl patch after forefoot surgery/ Jalkateräleikkauksen jälkeinen kivunhoito kipulaastarilla”.
    Medical condition: The patients will be recruited from 18-75 year old male or female patients undergoing hallux valgus or hallux rigidus surgery.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019095 Hallux Valgus correction LLT
    9.1 10019092 Hallux rigidus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000217-21 Sponsor Protocol Number: 310816 Start Date*: 2018-03-22
    Sponsor Name:Aarhus University Hospital
    Full Title: Do use of torniquete reduce the impact of the antibiotic treatment during orthopedic treatment?
    Medical condition: Orthopedic infections
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10019095 Hallux Valgus correction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2012-005573-31 Sponsor Protocol Number: SO Start Date*: 2013-02-07
    Sponsor Name:zna middelheim
    Full Title: Effects of the combination of dexamethasone or clonidine with ropivacaine during a popliteal block : a prospective double blind randomized trial.
    Medical condition: Foot and ankle surgery is associated with postoperative pain. Although single shot sciatic nerve blockade at the popliteal fossa (SSPFB) minimizes the administration of opioids, the duration of ana...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004865 10011123 Correction Hallux Valgus LLT
    14.1 100000004865 10019095 Hallux Valgus correction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000791-24 Sponsor Protocol Number: 2008HV001 Start Date*: 2008-05-05
    Sponsor Name:Karolinska Institutet
    Full Title: The effect of anti-inflammatory analgesics on pain after Hallux Valgus surgery; a prospective randomised study comparing a weak opioid and a Coxib.
    Medical condition: Postoperative pain, pain following elective Hallux Valgus surery ad modum Turan
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036236 Postoperative pain relief LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2016-000961-22 Sponsor Protocol Number: 16/009U Start Date*: 2016-11-14
    Sponsor Name:Ziekenhuis Oost-Limburg
    Full Title: Quality of analgesia after ultrasound-guided specific blocks of the distal tibial and deep peroneal nerves with 15 mL of a 50:50 mixture bupivacaine 0.5% and liposome bupivacaine (Exparel®) )1.3% ...
    Medical condition: Hallux valgus
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-020547-13 Sponsor Protocol Number: 201001 Start Date*: 2011-08-24
    Sponsor Name:Foot and Ankle Surgical center
    Full Title: A randomized study comparing etoricoxib and diclofenac sodium in post hallux valgus surgery pain
    Medical condition: Postoperative pain
    Disease: Version SOC Term Classification Code Term Level
    12.1 10056350 Pain management PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000846-30 Sponsor Protocol Number: 08I/DCsc04 Start Date*: 2008-07-30
    Sponsor Name:IBSA
    Full Title: Open-label, randomised, controlled, parallel group study for the evaluation of safety and efficacy of Diclofenac HPBCD 75 mg ampoules s.c. in comparison with Diclofenac HPBCD 75 mg ampoules i.m. an...
    Medical condition: Post-surgical pain in subjects undergoing one of the following minor orthopaedic interventions: arthroscopic meniscectomy, arthroscopic removal of bone fragments, surgical correction of hallux valgus;
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061226 Limb operation LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-003253-32 Sponsor Protocol Number: BRD/08/5-D Start Date*: 2008-10-22
    Sponsor Name:Centre Hospitalier Universitaire de Nantes
    Full Title: Anesthésie régionale pour chirurgie majeure du pied. Levobupivacaïne 0,5% versus Ropivacaïne 0,5% dans le bloc sciatique par voie médiofémorale.
    Medical condition: Anesthésie régionale pour la chirurgie majeure du pied.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-002344-99 Sponsor Protocol Number: SKY0402-C-203 Start Date*: 2005-03-03
    Sponsor Name:SkyePharma, Inc.
    Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Escalating/De-Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sustained-Release Encapsulated Bupivacaine (SKY0402) ...
    Medical condition: Pain following bunionectomy
    Disease: Version SOC Term Classification Code Term Level
    6.0 10006586 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-006270-13 Sponsor Protocol Number: XCEL-MEN-01 Start Date*: 2013-01-08
    Sponsor Name:Banc de Sang i Teixits
    Full Title: A phase I-IIa safety and efficacy pilot clinical trial of intraarticular administration of autologous mesenchymal stem cells in meniscus injury
    Medical condition: Degenerative meniscal lesion
    Disease: Version SOC Term Classification Code Term Level
    15.0 10028395 - Musculoskeletal and connective tissue disorders 10069364 Meniscal degeneration PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2018-001983-49 Sponsor Protocol Number: UX023-CL205 Start Date*: 2019-10-10
    Sponsor Name:Ultragenyx Pharmaceutical Inc
    Full Title: An Open-Label, Phase 2 Study to Assess the Safety, Pharmacodynamics, and Efficacy of KRN23 in Children from 1 to 4 Years Old with X-linked Hypophosphatemia (XLH)
    Medical condition: XLH is a disorder of hypophosphatemia, renal phosphate wasting, and the most common inheritable form of rickets. In XLH patients, excess circulating fibroblast growth factor (FGF23) impair phosphat...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004850 10016206 Familial hypophosphataemic rickets LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-019109-40 Sponsor Protocol Number: XC0409 Start Date*: 2011-03-25
    Sponsor Name:Xenome Ltd
    Full Title: A multicenter, randomized, observer-blinded, single-dose, placebo-controlled, sequential cohort study of the efficacy and safety of Xen2174 in subjects following bunionectomy surgery
    Medical condition: Moderate to severe acute post-operative pain in subjects following primary unilateral first metatarsal bunionectomy
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10028395 Musculoskeletal and connective tissue disorders SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-000469-19 Sponsor Protocol Number: BUR-CL207 Start Date*: 2020-11-03
    Sponsor Name:Kyowa Kirin Pharmaceutical Development Ltd.
    Full Title: A Phase 1/2, Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Ag...
    Medical condition: XLH is a rare, genetic disorder that is serious, chronically debilitating and represents an unmet medical need. This genetic deficiency is estimated to occur in about 1:20,000 live births (Burnett ...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004850 10016206 Familial hypophosphataemic rickets LLT
    Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) DE (Prematurely Ended) SE (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-000600-29 Sponsor Protocol Number: UX023-CL301 Start Date*: 2016-09-15
    Sponsor Name:Ultragenyx Pharmaceuticals Inc
    Full Title: A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients with X-linked Hypophosphatemia (XLH)
    Medical condition: X-linked hypophosphatemia (XLH) is a disorder of renal phosphate wasting, defective bone mineralisation, and impaired growth plate or endochondral ossification caused by inactivating mutations in t...
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004850 10016206 Familial hypophosphataemic rickets LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) IE (Completed) DE (Completed) ES (Prematurely Ended) SE (Completed) GB (Completed) IT (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue May 20 21:31:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA